Fujita Health University School of Medicine/Fujita Health University Hospital/Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University/Department of Hematology and Oncology, RIRBM, Hiroshima University
About Fujita Health University School of Medicine/Fujita Health University Hospital/Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University/Department of Hematology and Oncology, RIRBM, Hiroshima University
2021 - 2024 Construction of health self-management system by developing hemoglobin measurement application
2018 - 2023 リンパ節間葉系間質細胞の生物学的特性解明と濾胞性リンパ腫薬物治療への応用
2017 - 2020 Repairing of radiation-induced tissue damage by extracellular vesicles that mediate interaction of tissue-specific stem cells
2015 - 2018 Targeting of bone marrow mesenchymal stromal/stem cells for the treatment of B cell acute lymphoblastic leukemia
2014 - 2017 Development of comprehensive cellular therapy for acute and late-onset radiation-induced injuries
2012 - 2015 Novel therapeutics targeting the specified metabolic pathway and transcription factor related to stem cells of chronic myelogenous leukemia
Yoshinobu Takakura, Rikinari Hanayama, Kazunari Akiyoshi, Shiroh Futaki, Kyoko Hida, Takanori Ichiki, Akiko Ishii-Watabe, Masahiko Kuroda, Kazushige Maki, Yasuo Miura, et al. Quality and Safety Considerations for Therapeutic Products Based on Extracellular Vesicles. Pharmaceutical research. 2024. 41. 1573-1594
Sumie Fujii, Yasuo Miura. Lenalidomide and pomalidomide modulate hematopoietic cell expansion and differentiation in the presence of MSC. International Journal of Hematology. 2024. 120. 3. 278-289
2005 - NIH NIH Fellows Award for Research Excellence 2005
Association Membership(s) (10):
American Society of Hematology
, 近畿血液学地方会・評議員
, THE JAPAN SOCIETY OF TRANSFUSION MEDICINE AND CELL THERAPY
, 日本造血細胞移植学会・評議員
, 日本造血細胞移植学会・認定医
, 日本血液学会・評議員
, THE JAPANESE SOCIETY OF HEMATOLOGY
, 日本内科学会・総合内科専門医
, American Association of Blood Banks
, 日本輸血・細胞治療学会 評議員